ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print May 30, 2007, 10.1183/09031936.00051906
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hernández, C.
Right arrow Articles by Jiménez, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hernández, C.
Right arrow Articles by Jiménez, A.
Eur Respir J 2007; 30:496-500
Copyright ©ERS Journals Ltd 2007

Nocturnal melatonin plasma levels in patients with OSAS: the effect of CPAP

C. Hernández1,2, J. Abreu1,2, P. Abreu3, A. Castro1 and A. Jiménez2

1 Service of Pneumology, and, 2 Research Unit, Hospital Universitario de Canarias, and 3 Dept of Physiology, Faculty of Medicine, University of La Laguna, La Laguna, Tenerife, Spain.

CORRESPONDENCE: C. Hernández, Service of Pneumology, Hospital Universitario de Canarias, Urbanización Ofra s/n, E-38320 La Laguna, Tenerife, Spain. Fax: 34 922600562. E-mail: chernandezg{at}teleline.es

Keywords: Continuous positive airway pressure titration, melatonin secretion, obstructive sleep apnoea syndrome

Received: April 16, 2006
Accepted May 16, 2007

Melatonin is a pineal hormone that regulates the human cycle of sleep and wakefulness. Plasma melatonin levels were investigated in patients with obstructive sleep apnoea syndrome (OSAS).

In total, 20 patients with OSAS and 11 healthy controls were studied. OSAS patients were tested twice: on the night of diagnostic polysomnography and the night of continuous positive airway pressure (CPAP) titration. Controls were tested on one occasion. Plasma melatonin levels were determined at 23:00 h (light period), at 02:00 h (dark period) and at 06:00 h (light period) in patients and control subjects using the radioimmunoassay method.

The control subjects showed a nocturnal melatonin peak value at 02:00 h (70.6±14 pg·mL–1). However, this nocturnal melatonin peak was absent in the OSAS patients. The highest melatonin value was found in OSAS patients on the night of diagnosis, at 06:00 h (49.3±36.8 pg·mL–1). It was found that the melatonin level in OSAS patients at 06:00 h was significantly lower in the night of titration (35.6±37.9 pg·mL–1) than in the diagnosis night. However, the melatonin levels at either 23:00 h or 02:00 h in OSAS patients did not differ significantly when comparing levels in the night of diagnostic polysomnography (23:00 h: 31.6±29.8 pg·mL–1; 02:00 h: 47.4±33.8 pg·mL–1) with levels in the night of CPAP titration (23:00 h: 20.2±10.3 pg·mL–1; 02:00 h: 37.7±27.5 pg·mL–1).

Patients with obstructive sleep apnoea syndrome have an abnormal melatonin secretion pattern. The absence of a nocturnal serum melatonin peak could be partially related to the difficulty that these patients have in achieving a normal sleep–wakefulness pattern.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the European Respiratory Society.